Angelo Agathanggelou

Publications

  1. 1994
  2. Published
  3. 1995
  4. Published
  5. 2001
  6. Published
  7. Published
  8. Published
  9. Published
  10. 2002
  11. Published
  12. Published
  13. 2003
  14. Published
  15. Published
  16. Published

    Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers

    Angelo Agathanggelou, Ashraf Dallol, Eamonn Maher & Farida Latif, 13 Mar 2003, In: Oncogene. 22, 10, p. 1580-1588 9 p.

    Research output: Contribution to journalArticle

  17. 2004
  18. Published
  19. Published
  20. Published
  21. 2005
  22. Published

    Involvement of the RASSF1A tumor suppressor gene in controlling cell migration

    Ashraf Dallol, Angelo Agathanggelou, Eamonn Maher & Farida Latif, 1 Jan 2005, In: Cancer Research. 65, 17, p. 7653-7659 7 p.

    Research output: Contribution to journalArticle

  23. Published
  24. Published
  25. 2007
  26. Published
  27. 2009
  28. Published
  29. 2010
  30. Published
  31. 2013
  32. Published
  33. Published

    Synthetic Lethality In CLL With DNA Damage Response Defect By Targeting ATR Pathway

    Tatjana Stankovic, Nick Davies, Marwan Cheng Kuang Kwok, Angelo Agathanggelou, 15 Nov 2013, Blood. Vol. 122. p. 120 (Blood).

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  34. 2014
  35. Published
  36. Published

    CLL Progression Is Associated with Increased Clonal Diversity and Replication Stress

    Angelo Agathanggelou, Anna Skowronska, Nick Davies, Marwan Cheng Kuang Kwok, Malcolm Taylor & Tatjana Stankovic, 6 Dec 2014, Blood. Vol. 124. p. 1977 (Blood).

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  37. 2015
  38. Published
  39. Published
  40. Published
  41. Published
  42. 2016
  43. Published
  44. 2017
  45. Published
  46. Published
  47. 2018
  48. E-pub ahead of print
  49. Published

    CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

    Angelo Agathanggelou, Paul Moss & 4 others, , Tatjana Stankovic, 4 Jul 2018, In: Nature. 559, 7713, p. 285-289 5 p.

    Research output: Contribution to journalArticlepeer-review

  50. 2019
  51. Published

    Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia

    Ruth Roberts & 4 others, Tatjana Stankovic, John Fossey & Angelo Agathanggelou, 1 Aug 2019, In: Medchemcomm. 10, 8, p. 1379-1390 12 p.

    Research output: Contribution to journalArticlepeer-review

  52. 2020
  53. Published
  54. Published